Electrochemical Detection of Diclofenac Using a Screen-Printed Electrode Modified with Graphene Oxide and Phenanthroline

In recent years, interest in screen-printed electrodes (SPEs) has grown due to their wide range of applications. Diclofenac (DCF), a widely used non-steroidal anti-inflammatory drug, is a subject of interest in pharmaceutical research as well as environmental research, primarily due to its environmental contamination and therapeutic applications. This study describes the development and characterization of an innovative screen-printed sensor based on graphene oxide (GO) and phenanthroline (PHEN) for the rapid and highly sensitive determination of diclofenac. The modified sensor was characterized by Fourier Transform Infrared (FT-IR) spectroscopy and scanning electron microscopy (SEM). The electrochemical behavior of the screen-printed electrodes was assessed through cyclic voltammetry (CV) in phosphate buffer solution (PBS) and potassium ferrocyanide/potassium ferricyanide solution. The cyclic voltammograms of the electrodes modified with GO and PHEN revealed peaks in PBS related to redox processes of PHEN immobilized in the carbonaceous matrix. Additionally, the active surface area of the electrodes was found to be larger for the modified carbon screen-printed electrode with GO and PHEN, which also showed improved sensitivity to the detection of DCF. The limit of detection (1.53 nM) and the sensitivity of the novel sensor were promising, and these performance characteristics enabled the sensitive detection of DCF in different pharmaceutical products. The selectivity was confirmed to be appropriate based on recovery studies conducted with the pharmaceutical products, which produced values close to 100%.